- Home
- MPLT vs NIE Comparison
MPLT vs NIE Comparison
Compare MPLT & NIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPLT
- NIE
- Stock Information
- Founded
- MPLT 2018
- NIE 2007
- Country
- MPLT United States
- NIE United States
- Employees
- MPLT N/A
- NIE N/A
- Industry
- MPLT Biotechnology: Pharmaceutical Preparations
- NIE Investment Managers
- Sector
- MPLT Health Care
- NIE Finance
- Exchange
- MPLT Nasdaq
- NIE Nasdaq
- Market Cap
- MPLT 700.6M
- NIE 718.5M
- IPO Year
- MPLT 2025
- NIE N/A
- Fundamental
- Price
- MPLT $12.94
- NIE $25.27
- Analyst Decision
- MPLT Strong Buy
- NIE
- Analyst Count
- MPLT 4
- NIE 0
- Target Price
- MPLT $31.00
- NIE N/A
- AVG Volume (30 Days)
- MPLT 233.6K
- NIE 70.5K
- Earning Date
- MPLT 12-09-2025
- NIE 01-01-0001
- Dividend Yield
- MPLT N/A
- NIE 9.04%
- EPS Growth
- MPLT N/A
- NIE N/A
- EPS
- MPLT N/A
- NIE N/A
- Revenue
- MPLT N/A
- NIE N/A
- Revenue This Year
- MPLT N/A
- NIE N/A
- Revenue Next Year
- MPLT N/A
- NIE N/A
- P/E Ratio
- MPLT N/A
- NIE N/A
- Revenue Growth
- MPLT N/A
- NIE N/A
- 52 Week Low
- MPLT $12.77
- NIE $18.61
- 52 Week High
- MPLT $20.86
- NIE $22.47
- Technical
- Relative Strength Index (RSI)
- MPLT N/A
- NIE 50.19
- Support Level
- MPLT N/A
- NIE $24.50
- Resistance Level
- MPLT N/A
- NIE $25.30
- Average True Range (ATR)
- MPLT 0.00
- NIE 0.39
- MACD
- MPLT 0.00
- NIE -0.06
- Stochastic Oscillator
- MPLT 0.00
- NIE 57.29
About MPLT MapLight Therapeutics Inc. Common Stock
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.
About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. The investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments, such as aerospace and defense, banks, IT services, software, and others.